初诊2型糖尿病患者访视间HbA1c变异性与心血管疾病及微血管并发症相关
该回顾性队列研究纳入苏格兰SCI-DC数据库中初诊2型糖尿病患者,要求诊断后至结局评估前至少有5次HbA1c测量,采用HbA1c变异性评分(HVS)评估访视间HbA1c波动。结果发现HVS>60%的患者所有结局风险均升高,且四种敏感性分析(包括校正时间加权平均HbA1c)证实结果稳健,提示高HbA1c变异性独立于高HbA1c水平增加全因死亡、心血管事件及微血管并发症风险。
要点
- HVS>60%与全因死亡、心血管事件及微血管并发症风险升高相关。
- HVS>80%至≤100% vs HVS≥0%至≤20%时主要不良心血管事件HR为2.38(95%CI 1.61-3.53)。
- 校正时间加权平均HbA1c后结果仍稳健,提示变异性独立于高HbA1c水平。
核心结论
- 较高的HbA1c变异性与全因死亡、心血管事件及糖尿病微血管并发症风险增加相关,且独立于高HbA1c水平。
研究设计与样本
- 回顾性队列研究,分析苏格兰Tayside和Fife地区SCI-DC数据库中从糖尿病诊断起可观察且结局评估前至少有5次HbA1c测量的初诊2型糖尿病患者,每个结局分析纳入13,111至19,883例患者。
- 采用HbA1c变异性评分(HVS),计算个体所有HbA1c测量中变化>0.5%(5.5 mmol/mol)的次数百分比,使用Cox比例风险模型评估HVS与10种结局的关联。
主要发现
- HVS>60%的患者与最低五分位组相比,所有结局风险均升高;HVS>80%至≤100% vs HVS≥0%至≤20%时,主要不良心血管事件HR 2.38(95%CI 1.61-3.53),全因死亡HR 2.4(95%CI 1.72-3.33),动脉粥样硬化性心血管死亡HR 2.4(95%CI 1.13-5.11)。
- HVS>80%至≤100% vs HVS≥0%至≤20%时,冠状动脉疾病HR 2.63(95%CI 1.81-3.84),缺血性卒中HR 2.04(95%CI 1.12-3.73),心力衰竭HR 3.23(95%CI 1.76-5.93)。
- HVS>80%至≤100% vs HVS≥0%至≤20%时,糖尿病视网膜病变HR 7.4(95%CI 3.84-14.27),糖尿病周围神经病变HR 3.07(95%CI 2.23-4.22),糖尿病足溃疡HR 5.24(95%CI 2.61-10.49),新发慢性肾脏病HR 3.49(95%CI 2.47-4.95)。
- 四项敏感性分析(包括校正时间加权平均HbA1c)证实结果稳健。
临床怎么用
- 在初诊2型糖尿病管理中,除关注平均HbA1c水平外,应评估访视间HbA1c变异性(如HVS)以识别心血管及微血管并发症高风险患者。
- HVS>60%提示风险升高,尤其是HVS>80%至≤100%时风险显著增加,可考虑作为风险分层和强化管理的参考指标。
- 干预策略除降低平均血糖外,应关注减少HbA1c波动,以可能降低长期并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between visit-to-visit HbA1c variability and cardiovascular events and microvascular complications in patients with newly diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: This retrospective cohort study analyzed patients from Tayside and Fife in the Scottish Care Information-Diabetes Collaboration (SCI-DC) who were observable from the diagnosis of diabetes and had at least five HbA1c measurements before the outcomes were evaluated. We used the previously reported HbA1c variability score (HVS), calculated as the percentage of the number of changes in HbA1c >0.5% (5.5 mmol/mol) among all HbA1c measurements within an individual. The association between HVS and 10 outcomes was assessed using Cox proportional hazards models. RESULTS: We included 13,111-19,883 patients in the analyses of each outcome. The patients with HVS >60% were associated with elevated risks of all outcomes compared with the lowest quintile (for example, HVS >80 to ≤100 vs. HVS ≥0 to ≤20, hazard ratio 2.38 [95% CI 1.61-3.53] for major adverse cardiovascular events, 2.4 [1.72-3.33] for all-cause mortality, 2.4 [1.13-5.11] for atherosclerotic cardiovascular death, 2.63 [1.81-3.84] for coronary artery disease, 2.04 [1.12-3.73] for ischemic stroke, 3.23 [1.76-5.93] for heart failure, 7.4 [3.84-14.27] for diabetic retinopathy, 3.07 [2.23-4.22] for diabetic peripheral neuropathy, 5.24 [2.61-10.49] for diabetic foot ulcer, and 3.49 [2.47-4.95] for new-onset chronic kidney disease). Four sensitivity analyses, including adjustment for time-weighted average HbA1c, confirmed the robustness of the results. CONCLUSIONS: Our study shows that higher HbA1c variability is associated with increased risks of all-cause mortality, cardiovascular events, and microvascular complications of diabetes independently of high HbA1c.
引用
- Li S, Nemeth I, Donnelly L, et al. Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes. Diabetes Care. 2019. PMID: 31727686. doi:10.2337/dc19-0823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。